Chronic treatment with electroconvulsive shock may modulate the immune function of macrophages

Journal of ECT

Volumn 24, Issue 4, 2008, Pages 260-267

  Roman, Adam ^a   Nawrat, Dominika ^a   Nalepa, Irena ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Alamar Blue; Arginase; Electroconvulsive treatment; Macrophages; MTT; Nitric oxide; Redox status of the cells

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ARGINASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITROBLUE TETRAZOLIUM; OXAZINE DERIVATIVE; RESAZURIN; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; UNCLASSIFIED DRUG; XANTHENE DERIVATIVE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; ELECTROCONVULSIVE THERAPY; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; INCUBATION TIME; LONG TERM CARE; MALE; NONHUMAN; PERITONEUM MACROPHAGE; PINOCYTOSIS; RAT; SHAM PROCEDURE; SYNTHESIS; THERAPY EFFECT; WISTAR RAT; ANIMAL; BIOSYNTHESIS; CELL SURVIVAL; CELLULAR IMMUNITY; DRUG EFFECT; ELECTRIC SHOCK; ENZYMOLOGY; IMMUNOLOGY; RADIATION EXPOSURE;

ANIMALS; ARGINASE; CELL ADHESION; CELL SURVIVAL; ELECTROSHOCK; IMMUNITY, CELLULAR; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; NITRIC OXIDE; NITROBLUE TETRAZOLIUM; OXAZINES; PINOCYTOSIS; RATS; TETRAZOLIUM SALTS; THIAZOLES; XANTHENES;

EID: 61949204651     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e31816726ae     Document Type: Article

References (49)

1. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 1995;19:11-38.
2. Kronfol Z. Immune dysregulation in major depression: a critical review of existing evidence. Int J Neuropsychopharmacol. 2002; 5:333-343.
3. Smith RS. The macrophage theory of depression. Med Hypotheses. 1991;35:298-306.
4. Maes M, Smith R, Scharpe S. The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology. 1995;20: 111-116.
5. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res. 1996;711:163-174.
6. Yirmiya R, Pollak Y, Barak O, et al. Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology. 2001;24:531-544.
7. Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29: 201-217.
8. Wichers M, Maes M. The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. Int J Neuropsychopharmacol. 2002;5:375-388.
9. Leonard BE, Song C. Changes in the immune system in rodent models of depression. Int J Neuropsychopharmacol. 2002;5:345-356.
10. Ma J, Chen T, Mandelin J, et al. Regulation of macrophage activation. Cell Mol Life Sci. 2003;60:2334-2346.
11. H2 phenotype. J Immunol. 1998;160:5347-5354.
12. H2 paradigm. J Immunol. 2000;164:6166-6173.
13. Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002;23: 549-555.
14. Anderson CF, Mosser DM. A novel phenotype for an activated macrophage: the type 2 activated macrophage. J Leukoc Biol. 2002; 72:101-106.
15. Stout RD, Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol. 2004;76: 509-513.
16. Stout RD, Jiang C, Matta B, et al. Macrophages sequentially change thei functional phenotype in response to changes in microenvironmental influences. J Immunol. 2005;175:342-349.
17. Pagnin D, de Queiroz V, Pini S, et al. Efficacy of ECT in depression: a meta-analytic review. J ECT. 2004;20:13-20.
18. Hestad KA, Tonseth S, Stoen CD, et al. Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT. 2003;19:183-188.
19. Vlajkovic S, Jankovic BD. Experimental epilepsy: electrically and chemically induced convulsions modulate experimental allergic encephalomyelitis and other immune inflammatory reactions in the rat. Int J Neurosci. 1990;54:165-172.
20. Roman A, Nalepa I. Effect of repeated administration of paroxetine and electroconvulsive shock (ECS) on the proliferative response of lymphocytes and the synthesis of nitric oxide by macrophages in rats. J ECT. 2005;21:111-117.
21. Zhi-Jun Y, Sriranganathan N, Vaught T, et al. A dye-based lymphocyte proliferation assay that permits multiple immunological analyses: mRNA, cytogenetic, apoptosis, and immunophenotyping studies. J Immunol Methods. 1997;210:25-39.
22. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
23. Rook GA, Steele J, Umar S, et al. A simple method for the solubilisation of reduced NBT, and its use as a colorimetric assay for activation of human macrophages by gamma-interferon. J Immunol Methods. 1985; 82:161-167.
24. Plytycz B, Rózanowska M, Seljelid R. Quantification of neutral red pinocytosis by small numbers of adherent cells: comparative studies. Folia Biol (Kraków). 1992;40:3-9.
25. Corraliza IM, Campo ML, Soler G, et al. Determination of arginase activity in macrophages: a micromethod. J Immunol Methods. 1994;174: 231-235.
26. Martin JH, Edwards SW. Changes in mechanisms of monocyte/ macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing. J Immunol. 1993;150:3478-3486.
27. Back SA, Khan R, Gan X, et al. A new Alamar Blue viability assay to rapidly quantify oligodendrocyte death. J Neurosci Methods. 1999;91: 47-54.
28. O'Brien J, Wilson I, Orton T, et al. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem. 2000;267:5421-5426.
29. Ahmed SA, Gogal RM Jr, Walsh JE. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immunol Methods. 1994;170:211-224.
30. Abe T, Takahashi S, Fukuuchi Y. Reduction of Alamar Blue, a novel redox indicator, is dependent on both the glycolytic and oxidative metabolism of glucose in rat cultured neurons. Neurosci Lett. 2002;326: 179-182.
31. Takahashi S, Abe T, Gotoh J, et al. Substrate-dependence of reduction of MTT: a tetrazolium dye differs in cultured astroglia and neurons. Neurochem Int. 2002;40:441-448.
32. Berridge MV, Herst PM, Tan AS. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev. 2005;11:127-152.
33. Springer JE, Azbill RD, Carlson SL. A rapid and sensitive assay for measuring mitochondrial metabolic activity in isolated neural tissue. Brain Res Protoc. 1998;2:259-563.
34. Zhang HX, Du GH, Zhang JT. Assay of mitochondrial functions by resazurin in vitro. Acta Pharmacol Sin. 2004;25:385-389.
35. Abu-Amero KK, Bosley TM. Detection of mitochondrial respiratory dysfunction in circulating lymphocytes using resazurin. Arch Pathol Lab Med. 2005;129:1295-1298.
36. Gonzalez RJ, Tarloff JB. Evaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activity. Toxicol In Vitro. 2001;15: 257-259.
37. Bernas T, Dobrucki J. Mitochondrial and nonmitochondrial reduction of MTT: interaction of MTT with TMRE, JC-1, and NAO mitochondrial fluorescent probes. Cytometry. 2002;47:236-242.
38. Liu Y, Peterson DA, Kimura H, et al. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem. 1997;69:581-593.
39. Makarov P, Kropf S, Wiswedel I, et al. Consumption of redox energy by glutathione metabolism contributes to hypoxia/reoxygenation-induced injury in astrocytes. Mol Cell Biochem. 2006;286:95-101.
40. Petrenko YA, Gorokhova NA, Tkachova EN, et al. The reduction of Alamar Blue by peripheral blood lymphocytes and isolated mitochondria. Ukr Biokhim Zh. 2005;77:100-105.
41. Pozzolini M, Scarfi S, Benatti U, et al. Interference in MTT cell viability assay in activated macrophage cell line. Anal Biochem. 2003; 313:338-3341.
42. Forman HJ, Torres M. Redox signaling in macrophages. Mol Aspects Med. 2001;22:189-216.
43. Oktyabrsky ON, Smirnova GV. Redox regulation of cellular functions. Biochemistry (Mosc). 2007;72:132-145.
44. H2 response patterns. Proc Natl Acad Sci U S A. 1998;95:3071-3076.
45. Murata Y, Shimamura T, Hamuro J. The polarization of T(h)1/T(h)2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine production. Int Immunol. 2002;14:201-212.
46. van Praag HM. Can stress cause depression? Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:891-907.
47. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology. 2005;52:90-110.
48. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27:24-31.
49. Nishida A, Hisaoka K, Zensho H, et al. Antidepressant drugs and cytokines in mood disorders. Int Immunopharmacol. 2002;2:1619-1626.